Literature DB >> 8644752

Germ-line BRCA1 mutations in selected men with prostate cancer.

A A Langston, J L Stanford, K G Wicklund, J D Thompson, R G Blazej, E A Ostrander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8644752      PMCID： PMC1914660     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  23 in total

1.  Two one-step methods for household screening and interviewing using random digit dialing.

Authors:  B L Harlow; S Davis
Journal:  Am J Epidemiol       Date:  1988-04       Impact factor: 4.897

2.  Concerning a familial association between breast cancer and both prostatic and uterine malignancies.

Authors:  E U Thiessen
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

3.  Linkage of early-onset familial breast cancer to chromosome 17q21.

Authors:  J M Hall; M K Lee; B Newman; J E Morrow; L A Anderson; B Huey; M C King
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

4.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

5.  Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.

Authors:  J P Struewing; L C Brody; M R Erdos; R G Kase; T R Giambarresi; S A Smith; F S Collins; M A Tucker
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

6.  Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.

Authors:  D Ford; D F Easton; J Peto
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

7.  BRCA1 mutations in a population-based sample of young women with breast cancer.

Authors:  A A Langston; K E Malone; J D Thompson; J R Daling; E A Ostrander
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

8.  Mutation analysis of the BRCA1 gene in ovarian cancers.

Authors:  H Takahashi; K Behbakht; P E McGovern; H C Chiu; F J Couch; B L Weber; L S Friedman; M C King; M Furusato; V A LiVolsi
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

9.  Risk of cancer in relatives of prostate cancer probands.

Authors:  S D Isaacs; L A Kiemeney; A Baffoe-Bonnie; T H Beaty; P C Walsh
Journal:  J Natl Cancer Inst       Date:  1995-07-05       Impact factor: 13.506

10.  Familial breast cancer risks. Effects of prostate and other cancers.

Authors:  D E Anderson; M D Badzioch
Journal:  Cancer       Date:  1993-07-01       Impact factor: 6.860
View more
  6 in total

1.  The 12 base pair duplication/insertion alteration could be a regulatory mutation.

Authors:  M Robledo; A Osorio; C Sentís; J Albertos; L Estevez; J Benítez
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

2.  The 2013 Genetics Society of America Medal: Elaine A. Ostrander.

Authors:  John Schimenti; Marnie Halpern
Journal:  Genetics       Date:  2013-05       Impact factor: 4.562

3.  Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

Authors:  K L Nastiuk; M Mansukhani; M B Terry; P Kularatne; M A Rubin; J Melamed; M D Gammon; M Ittmann; J J Krolewski
Journal:  Prostate       Date:  1999-08-01       Impact factor: 4.104

4.  Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred.

Authors:  Florian D Vogl; Mike D Badzioch; Linda Steele; Susan L Neuhausen; David E Goldgar
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

5.  BRCA1 polymorphisms.

Authors:  I G Campbell; R Schroff; P Englefield; D M Eccles
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.

Authors:  A Vazina; J Baniel; Y Yaacobi; A Shtriker; D Engelstein; I Leibovitz; M Zehavi; A A Sidi; Y Ramon; T Tischler; P M Livne; E Friedman
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.